3B Blackbio Dx share news, announcements and annual reports
NSE: 3BBLACKBIOBSE: 532067Healthcare ServicesSmall Cap
3B Blackbio Dx Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1996
Last close ₹1,310.10up ₹14.40 (1.11%)BSE ₹1,309.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,295.70.
2 Nov: open ₹1,292.00, high ₹1,382.60, low ₹1,292.00
52-week range of BSE trades to 2 Nov 2026
₹1,083.50Low, 2 Jun 2026₹1,750.00High, 19 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,124 Cr1,399th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.25
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.47
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.38%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,90253.1% delivered
3B Blackbio Dx board meetings
112 filed, newest first. Page 2 of 3.
Oct 2021
Jul 2021
14 Jul · Board meeting
Meeting on 29 Jul 2021: quarterly results
Jun 2021
23 Jun · Board meeting
May 2021
10 May · Board meeting
Meeting on 23 Jun 2021: special dividend, final dividend, audited results and dividend
Jan 2021
13 Jan · Board meeting
Meeting on 5 Feb 2021: quarterly results
Dec 2020
24 Dec · Board meeting
Meeting on 30 Dec 2020
Nov 2020
7 Nov · Board meeting
Oct 2020
8 Oct · Board meeting
Meeting on 5 Nov 2020: quarterly results
Sep 2020
14 Sep · Board meeting
Meeting on 17 Sep 2020: amalgamation
Jul 2020
14 Jul · Board meeting
Meeting on 31 Jul 2020: quarterly results
Jun 2020
8 Jun · Board meeting
Meeting on 26 Jun 2020: audited results and final dividend
Mar 2020
4 Mar · Board meeting
Meeting on 12 Mar 2020: interim dividend
Jan 2020
10 Jan · Board meeting
Meeting on 11 Feb 2020: quarterly results
Oct 2019
15 Oct · Board meeting
Meeting on 11 Nov 2019: quarterly results
Jul 2019
15 Jul · Board meeting
Meeting on 29 Jul 2019: quarterly results
Jun 2019
10 Jun · Board meeting
Meeting on 17 Jun 2019: preferential issue of shares
May 2019
Apr 2019
30 Apr · Board meeting
Meeting on 23 May 2019: audited results and dividend
Jan 2019
3 Jan · Board meeting
Meeting on 24 Jan 2019: quarterly results
Nov 2018
27 Nov · Board meeting
Oct 2018
May 2018
23 May · Board meeting
Dec 2017
26 Dec · Board meeting
Nov 2017
22 Nov · Board meeting
22 Nov · Board meeting